Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
Authors:
- Neha KanojiaNKNeha Kanojia
- Komal ThapaKTKomal Thapa
- Gagandeep KaurGKGagandeep Kaur
- Ameya SharmaASAmeya Sharma
- Vivek PuriVPVivek Puri
- Nitin VermaNVNitin Verma
- 8 December 2022
- journal article
- review article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 79
Abstract
No abstract availableKeywords
Funding Information
- Chitkara University
This publication has 226 references indexed in Scilit:
- Development of a novel niosomal system for oral delivery of Ginkgo biloba extractInternational Journal of Nanomedicine, 2013
- Preparation, Biodistribution and Neurotoxicity of Liposomal Cisplatin following Convection Enhanced Delivery in Normal and F98 Glioma Bearing RatsPLOS ONE, 2012
- Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic studyInternational Journal of Nanomedicine, 2012
- Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptideNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Neuropathological Alterations in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissueBiomaterials, 2011
- DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD MicePLOS ONE, 2011
- Optimizing Liposomal Cisplatin Efficacy through Membrane Composition ManipulationsChemotherapy Research and Practice, 2011
- Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion proteinProceedings of the National Academy of Sciences, 2010
- Pharmacology of ginsenosides: a literature reviewChinese Medicine, 2010